Currently, the following drugs are approved for long-term treatment of obesity worldwide: Orlistat (Xenical, Xenical, Roche, Basel, Switzerland), 1999
Side Effects and Tolerability GLP-1 medications are generally well-tolerated, with the most common side effects being gastrointestinal issues such as nausea and vomiting
KPV for inflammatory shoulder conditions KPV peptide is a tripeptide derived from alpha-melanocyte-stimulating hormone with potent anti-inflammatory properties
compounds that target antioxidant defense system molecules: superoxide dismutase' catalase, glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, heme oxygenase, Nrf-2, kidney injury molecule-1, vitamin E, N-acetylcysteine, amifostine, ebselen ans allopurinol
Hormone replacement therapy (HRT) and GLP-1 weight loss medications, like Wegovy and Zepbound, are now being considered as complementary treatments that can help manage menopausal weight gain when used together
GLP-1 receptor agonists such as semaglutide [Wegovy] and liraglutide [Saxenda] were developed for diabetes and weight management, not ED
